# Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes

> **NCT04289948** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University Hospitals of Derby and Burton NHS Foundation Trust**

## Conditions studied

- Diabetes
- Diabetic Foot
- Diabetic Foot Infection

## Interventions

- **DRUG:** Phage

## Key facts

- **NCT ID:** NCT04289948
- **Lead sponsor:** University Hospitals of Derby and Burton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding issues meant that development of the study was halted.
- **Last updated:** 2020-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04289948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04289948, "Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04289948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*